95 related articles for article (PubMed ID: 3307599)
1. Activity and inhibition by cytotoxic and antimetastatic drugs of cathepsin B-like cysteine proteinase in transplantable leukemias in mice.
Giraldi T; Sava G; Zorzet S; Perissin L; Piccini P
Anticancer Res; 1987; 7(3 Pt B):343-6. PubMed ID: 3307599
[TBL] [Abstract][Full Text] [Related]
2. Proteinases and proteinase inhibition by cytotoxic and antimetastatic drugs in transplantable solid metastasizing tumors in mice.
Giraldi T; Sava G; Perissin L; Zorzet S
Anticancer Res; 1985; 5(4):355-9. PubMed ID: 3898994
[TBL] [Abstract][Full Text] [Related]
3. Tumor cell metastasis and surface neutral proteinase: effects of antimetastatic and antitumor drugs.
Giraldi T; Sava G; Perissin L; Zorzet S; Decorti G; Steven FS
Invasion Metastasis; 1985; 5(6):336-43. PubMed ID: 3905687
[TBL] [Abstract][Full Text] [Related]
4. Effects of antimetastatic, antiinvasive and cytotoxic agents on the growth and spread of transplantable leukemias in mice.
Sava G; Giraldi T; Perissin L; Zorzet S; Decorti G
Clin Exp Metastasis; 1987; 5(1):27-34. PubMed ID: 2951046
[TBL] [Abstract][Full Text] [Related]
5. Selectivity of the antimetastatic and cytotoxic effects of 1-p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt (+/-)-1,2-di(3,5-dioxopiperazin-1-yl)propane, and cyclophosphamide in mice bearing Lewis lung carcinoma.
Giraldi T; Sava G; Cuman R; Nisi C; Lassiani L
Cancer Res; 1981 Jun; 41(6):2524-8. PubMed ID: 7237446
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of cell-surface neutral protease of Ehrlich ascites tumor cells by potassium p-(3,3-dimethyl-1-triazeno) benzoate.
Steven FS; Brown BS; Hulley TP; Itzhaki S; Giraldi T; Lassiani L
Biochem Int; 1985 Aug; 11(2):153-60. PubMed ID: 3902023
[TBL] [Abstract][Full Text] [Related]
7. Antimetastatic activity of adriamycin in combinations with proteinase inhibitors in mice.
Leto G; Tumminello FM; Gebbia N; Woynarowska B; Bernacki RJ
Anticancer Res; 1990; 10(1):265-9. PubMed ID: 2334138
[TBL] [Abstract][Full Text] [Related]
8. The influence of Ukrain on the growth of HA-1 tumor in mice: the role of cysteine proteinases as markers of tumor malignancy.
Svechnikova IG; Korolenko TA; Stashko JuF ; Kaledin VI; Nikolin VP; Nowicky JW
Drugs Exp Clin Res; 1998; 24(5-6):261-9. PubMed ID: 10190085
[TBL] [Abstract][Full Text] [Related]
9. Selective inhibition of proteolytic enzymes in an in vivo mouse model for experimental metastasis.
Ostrowski LE; Ahsan A; Suthar BP; Pagast P; Bain DL; Wong C; Patel A; Schultz RM
Cancer Res; 1986 Aug; 46(8):4121-8. PubMed ID: 3089587
[TBL] [Abstract][Full Text] [Related]
10. Enhancing effect of new biological response modifier sulfoethylated (1-->3)-beta-D-glucan on antitumor activity of cyclophosphamide in the treatment of experimental murine leukoses.
Khalikova TA; Korolenko TA; Zhanaeva SY; Kaledin VI; Kogan G
Exp Oncol; 2006 Dec; 28(4):308-13. PubMed ID: 17285116
[TBL] [Abstract][Full Text] [Related]
11. Metabolism and mechanism of the antileukemic action of isomeric aryldimethyltriazenes.
Sava G; Giraldi T; Lassiani L; Nisi C
Cancer Treat Rep; 1982 Sep; 66(9):1751-5. PubMed ID: 7116350
[TBL] [Abstract][Full Text] [Related]
12. Cathepsin B to cysteine proteinase inhibitor balance in metastatic cell subpopulations isolated from murine tumors.
Rozhin J; Gomez AP; Ziegler GH; Nelson KK; Chang YS; Fong D; Onoda JM; Honn KV; Sloane BF
Cancer Res; 1990 Oct; 50(19):6278-84. PubMed ID: 2400991
[TBL] [Abstract][Full Text] [Related]
13. Identification of cell surface cathepsin B-like activity on murine melanomas and fibrosarcomas: modulation by butanol extraction.
Keren Z; LeGrue SJ
Cancer Res; 1988 Mar; 48(6):1416-21. PubMed ID: 3345513
[TBL] [Abstract][Full Text] [Related]
14. Extracellular cysteine proteinase and collagenase activities as a consequence of tumor-host interaction in the rabbit V2 carcinoma.
Baici A; Gyger-Marazzi M; Sträuli P
Invasion Metastasis; 1984; 4(1):13-27. PubMed ID: 6329987
[TBL] [Abstract][Full Text] [Related]
15. Infiltration of liver and brain by tumor cells in leukemic mice: prevention by dimethyltriazenes and cyclophosphamide.
Sava G; Giraldi T; Perissin L; Zorzet S; Mallardi F; Grill V
Tumori; 1984 Dec; 70(6):477-83. PubMed ID: 6531789
[TBL] [Abstract][Full Text] [Related]
16. Selective antimetastatic drugs (review).
Giraldi T; Sava G
Anticancer Res; 1981; 1(3):163-74. PubMed ID: 7044264
[No Abstract] [Full Text] [Related]
17. Relationship between modulation of natural killer cell activity and antitumor activity of bropirimine when used in combination with various types of chemotherapeutic drugs.
Li LH; DeKoning TF; Wallace TL
Cancer Res; 1987 Nov; 47(22):5894-900. PubMed ID: 3664490
[TBL] [Abstract][Full Text] [Related]
18. Chiral cyclopalladated complexes derived from N,N-dimethyl-1-phenethylamine with bridging bis(diphenylphosphine)ferrocene ligand as inhibitors of the cathepsin B activity and as antitumoral agents.
Bincoletto C; Tersariol IL; Oliveira CR; Dreher S; Fausto DM; Soufen MA; Nascimento FD; Caires AC
Bioorg Med Chem; 2005 Apr; 13(8):3047-55. PubMed ID: 15781414
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antitumor activity of aminoacid derivatives of the antimetastatic agent DM-COOK.
Lassiani L; de Nardo MM; Nisi C; Varnavas A
Farmaco Sci; 1988 Mar; 43(3):227-38. PubMed ID: 3417008
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a cysteine proteinase secreted by mouse mammary gland.
Recklies AD; Mort JS
Cancer Res; 1985 May; 45(5):2302-7. PubMed ID: 3886131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
